Public Health Agency of Canada (PHAC) – Emerging Science Group (ESG) Evidence Reviews

Evidence Brief on Protective Immunity Post Infection with Omicron

July 26, 2022

Evidence Brief on the associations and safety of COVID‑19 vaccination and post COVID‑19 condition, Update 2

July 7, 2022

Evidence brief on attitudes and acceptance of COVID‑19 booster doses: update 1

April 1, 2022

Evidence on the effectiveness and safety of ultraviolet germicidal irradiation technologies in reducing SARS-CoV-2 in the air of occupied rooms

March 18, 2022

Living Profile of SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern Highlights up to February 16, 2022

February 16, 2022

Evidence Brief on Parental and Adolescent Acceptance of COVID‑19 Vaccine for Those Aged 1-17

December 10, 2021

Evidence Brief on the Risk of COVID‑19 Transmission in Flight, Update 3

November 25, 2021

Evidence on the Virulence, Transmission and Impact of B.1.617.2 (Delta) among Children: Update 2, November 2021

November 19, 2021

Rapid Review on Protective Immunity Post Infection with SARS-CoV-2, Update 3

October 22, 2021

Rapid Review on Protective Immunity Post COVID‑19 Vaccination, Update 3

October 22, 2021

Evergreen Rapid Review on COVID‑19 Vaccine Attitudes and Uptake in Canada – Update 11

October 18, 2021

Living Summary of SARS-CoV-2 Variants of Concern: The Delta variant (B.1.617.2) profile Highlights up to September 15, 2021

September 15, 2021

Evidence Brief of SARS-CoV-2 Incubation Periods

August 17, 2021

Living Summary of SARS-CoV-2 Variants of Interest: The C.37 (Lambda) Variant Profile Highlights up to August 10, 2021

August 10, 2021

Living Summary of SARS-CoV-2 Variants of Concern: The Delta variant (B.1.617.2) profile, Highlights up to July 29, 2021

July 29, 2021

Evergreen Rapid Review on COVID‑19 Vaccine Attitudes and Uptake, Update 8

July 14, 2021

Living Summary of SARS-CoV-2 Variants of Concern: The Gamma variant (P.1) profile, Highlights up to July 1, 2021

July 1, 2021

Living Summary of SARS-CoV-2 Variants of Concern: The B.1.1.7 (Alpha) Variant Profile Highlights up to July 1, 2021

July 1, 2021

Living Summary of SARS-CoV-2 Variants of Concern: The Beta Variant (B.1.351) profile Highlights up to July 1, 2021

July 1, 2021

Evidence Brief of Ivermectin

June 23, 2021

Evidence Brief on the Therapeutic use of Vitamin D Supplementation for COVID‑19

May 27, 2021

Rapid Review on the Impact of School Closures and Re-openings on COVID‑19 Transmission

May 4, 2021

Evidence Brief on viral load and the likelihood of transmission during the infectious period of SARS-CoV-2

March 31, 2021

Evidence Brief on SARS-CoV-2 Variants of Concern and Transmission in Children

March 26, 2021

Rapid Review on SARS-CoV-2 Aerosol Transmission, Update 2

March 12, 2021

Evidence Brief of COVID‑19 Infectious Period in Immunosuppressed/ Immunocompromised Individuals

February 17, 2021

Evidence Brief of SARS-CoV-2 Risks in Arenas

February 12, 2021

Evidence Brief of SARS-CoV-2 contract tracing

February 10, 2021

Rapid Review of Multisystem Inflammatory Syndrome in Children (MIS-C)

January 28, 2021

Evidence brief of maximum incubation period

January 26, 2021

Evidence brief on adherence to isolation and quarantine recommendations during COVID‑19

January 20, 2021

Rapid Review on the Characteristics of Effective Non-Medical Face Masks in Reducing the Risk of SARS-CoV-2 Transmission

January 5, 2021

Evidence brief of COVID‑19 quarantine length reduction strategies and effectiveness, Update 1

December 3, 2020

Rapid review on the physiological effects of wearing face masks

December 2, 2020

Rapid review on the use of face masks to prevent COVID‑19 in community settings

December 1, 2020

Evidence on the clinical and epidemiological features of MIS-A associated with SARS-CoV-2 infection.

November 13, 2020

Evidence brief of potential health risks of hard-surface disinfectants in environments shared by school-aged children

October 8, 2020

Evidence brief on ethnicity and COVID‑19

September 22, 2020

Rapid review on infectious period

September 11, 2020

Evidence brief on SARS-COV-2 antibodies in patients that retest RT-PCR positive

September 9, 2020

Evidence brief on the risk of COVID‑19 outbreaks in the workplace (update)

August 25, 2020

An evidence brief on SARS-CoV-2 transmission risks associated with playing non-professional sports

August 20, 2020

Rapid Review of COVID‑19 hospitalizations and length of stay

August 20, 2020

Evidence brief of size of gatherings and characteristics of high risk transmission events

August 18, 2020

COVID‑19 summary of heating, ventilation, air conditioning (HVAC) systems and transmission of SARS-CoV-2

August 14, 2020

Evidence brief on the determinants of individual adherence to public health interventions for COVID‑19

July 23, 2020

Evidence brief on age-dependent transmission

July 22, 2020

Evidence brief of pregnancy and severity of COVID‑19

July 17, 2020

COVID‑19 summary of face shields to prevent transmission of SARS-CoV-2

July 7, 2020

COVID‑19 summary of SARS-CoV-2 transmission and singing/wind Instruments

July 5, 2020

Evidence brief on SARS-CoV-2 virus dispersion distance

June 24, 2020

Evidence brief on the infection risk from eye exposures to inform contact and droplet precautions

June 22, 2020

Evidence brief of de-escalation of social bubbles

June 19, 2020

Evidence brief of aerosol generating procedures in dental care settings

June 11, 2020

Evidence brief on infectiousness and symptom onset

June 4, 2020

With funding from the Government of Canada

Please complete this short survey to help us understand our impact. Thank you!

Give Feedback